𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Host immunity as a determinant of treatment outcome in Plasmodium falciparum malaria

✍ Scribed by Stephen J Rogerson; Rushika S Wijesinghe; Steven R Meshnick


Book ID
117791402
Publisher
The Lancet
Year
2010
Tongue
English
Weight
129 KB
Volume
10
Category
Article
ISSN
1473-3099

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Sulfadoxine-pyrimethamine for the treatm
✍ P. Deloron; J. Mayombo; A. Le Cardinal; J. Mezui-Me-Ndong; C. Bruzi-Baert; F. Le πŸ“‚ Article πŸ“… 2000 πŸ› Elsevier Science 🌐 English βš– 431 KB

Chloroquine can no longer be recommended as the first-line treatment for falciparum malaria in several parts of Africa, given the increasing resistance of Plasmodium falcipanrm to this drug. The sulfadoxinepyrimethamine combination (SP) is obviously an alternative candidate, that has already been se